In colorectal carcinoma, UBR5 knockdown inhibits cancer cell proliferation by reducing the expression of PYK2, which subsequently downregulates oxidative phosphorylation and suppresses metabolic reprogramming [80]. This evidence concerns the gene PTK2B and colorectal carcinoma.